MedTech News - by Andrew Celentano
Neurescue wins CE mark for cardiac arrest treatment device
Neurescue announced today that it received CE mark approval for its device designed to treat non-shockable cardiac arrest.
Stryker launches Incompass total ankle system
Stryker (NYSE: SYK)+
today announced the launch of its recently FDA-cleared Incompass total ankle system.
Varian wins CE Mark for Embozene microspheres in knee osteoarthritis
Varian announced its Embozene microspheres have received CE mark for genicular artery embolisation (GAE) to treat knee osteoarthritis.
FDA clears Microbot’s LIBERTY endovascular robot
The FDA’s clearance of LIBERTY follows the completion of Microbot’s pivotal trial in April 2025, achieving a 100% success rate in robotic navigation.
EU greenlights Onward’s ARC-EX system for spinal cord injury patients
ARC‑EX is the first system to receive a CE Mark in Europe specifically for improving hand and arm strength and sensation in adults with chronic, incomplete spinal cord injury.
Squishy ‘smart cartilage’ could target arthritis pain as soon as flareups begin
Researchers have developed a material that can sense tiny changes within the body, such as during an arthritis flareup, and release drugs exactly where and when they are needed.
First ‘perovskite camera’ can see inside the human body
Physicians rely on nuclear medicine scans, like SPECT scans, to watch the heart pump, track blood flow and detect diseases hidden deep inside the body. But today’s scanners depend on expensive detectors that are difficult to make.
Scientists reprogram cancer-protecting regulatory T cells to fight tumors
Indiana University School of Medicine scientists have developed a new method that shifts the behavior of immunosuppressive cells in tumors, turning them from cancer protectors into tumor fighters.